General Information of DTT (ID: TTA592U)

DTT Name Urate anion exchanger 1 (URAT1) DTT Info
UniProt ID
S22AC_HUMAN
Gene Name SLC22A12

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
Approved Drug(s)
Patented Agent(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lesinurad DMUR64T Hyperuricaemia 5C55.Y Approved [1]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
RDEA-684 DMNWYHD Gout FA25 Phase 2 [1]
RDEA3170 DM1TKG4 Hyperuricaemia 5C55.Y Phase 2 [2]
URC102 DMY89BN Gout FA25 Phase 2 [3]
------------------------------------------------------------------------------------
18 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-ethyl-3-(4-hydroxy) benzoyl benzofuran derivative 1 DMHYIAV N. A. N. A. Patented [4]
3-benzyloxyphenyloxoacetic acid derivative 1 DMB6M3Y N. A. N. A. Patented [4]
Benzene sulfonamide derivative 16 DMATBZW N. A. N. A. Patented [4]
Benzofurans derivative 1 DM4198Z N. A. N. A. Patented [4]
Benzoic acid derivative 1 DM5ZKR2 N. A. N. A. Patented [4]
Cycloalkyl acid derivative 1 DMXMGSP N. A. N. A. Patented [4]
Cycloalkyl acid derivative 2 DM09LY3 N. A. N. A. Patented [4]
Fused heterocyclic compound 12 DMSYD6Z N. A. N. A. Patented [4]
Phenylthioacetate derivative 1 DMTHXUC N. A. N. A. Patented [4]
PMID27414413-Compound-Figure6right DMUG9X0 N. A. N. A. Patented [4]
PMID27414413-Compound-Figure8right DMTZNSM N. A. N. A. Patented [4]
Ring-fused compound 1 DMUB7RV N. A. N. A. Patented [4]
Succinamide derivative 1 DMTXDSG N. A. N. A. Patented [4]
Sulfonamide derivative 10 DMA32GJ N. A. N. A. Patented [4]
Sulfonamide derivative 11 DMJBR86 N. A. N. A. Patented [4]
Tetrazole acetic acid derivative 1 DM52683 N. A. N. A. Patented [4]
Tihoacetate derivative 1 DM6QHO0 N. A. N. A. Patented [4]
Triazole propanedioic acid derivative 1 DM8LFGS N. A. N. A. Patented [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 18 Patented Agent(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Morin DM2OGZ5 Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1031).
2 The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013; 14: 164.
3 Clinical pipeline report, company report or official report of Chugai Pharmaceutical (2013).
4 Urate transporter URAT1 inhibitors: a patent review (2012 - 2015).Expert Opin Ther Pat. 2016 Jul 30:1-10.
5 Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) express... Drug Metab Dispos. 2007 Jun;35(6):981-6.